Introduction
Eukaryotic cells have a membranous labyrinth network called the endoplasmic reticulum (ER) that extends through the cytoplasm of the cell and is contiguous with the nuclear envelope. Proteins must be correctly folded and assembled in the ER prior to transit to intracellular organelles and the cell surface. As a processing plant for protein folding and posttranslational modification, the ER is exquisitely sensitive to alterations in homeostasis. A number of cellular stress conditions, such as perturbation in calcium homeostasis or redox status, elevated secretory protein synthesis, expression of misfolded proteins, sugar/glucose deprivation, altered glycosylation, and overloading of cholesterol can interfere with oxidative protein folding and subsequently lead to accumulation of unfolded or misfolded proteins in the ER lumen, which constitutes a fundamental threat to the cells. The ER has evolved highly specific signaling pathways to alter transcriptional and translational programs to cope with the accumulation of unfolded or misfolded proteins in the ER lumen. This adaptive response that couples the ER protein folding load with the ER protein folding capacity is termed the unfolded protein response (UPR) (1) (2) (3) (4) . Over the past ten years, significant progress has been made in understanding the mechanisms and roles of UPR signaling. Here we discuss the basic components of the UPR pathways, the physiological roles of the UPR signaling and the future direction of the field.
Three UPR Transducers and One Master Regulator
The basic components of the UPR pathway were first characterized in the budding yeast Saccharomyces cerevisiae in the early 1990s. The ER transmembrane protein kinase/endoribonuclease IRE1p/Ern1p was found to be essential for cell survival during ER stress, and was identified as the transducer to initiate UPR signaling (5, 6) . Thereafter, researchers found that all eukaryotic cells have conserved the essential and unique properties of IRE1p-mediated UPR signaling identified in yeast, but also evolved additional transducers to generate a diversity of responses. In mammals, the counterpart of yeast IRE1p has two isoforms: IRE1α and IRE1β. While IRE1α is expressed in most cells and tissues, IRE1β expression is primarily restricted to the intestinal epithelial cells (7, 8) . IRE1 encodes an N-terminal ER stress-sensing domain in the ER lumen, an ER transmembrane domain, and a serine/threonine kinase domain and a carboxy-terminal endoribonuclease domain in the cytosol (6,9,10) ( Figure 1 ). In addition to IRE1, higher eukaryotic cells have two additional UPR transducers: PKR-like ER kinase (PERK) and activating transcription factor 6 (ATF6). PERK contains a large ER luminal stresssensing domain that is functionally interchangeable with the IRE1 luminal domain, and a cytosolic domain that phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (eIF2α) (11) (12) (13) . ATF6 is a transcription factor with an N-terminal basic leucine zipper (b-ZIP) domain in the cytosol and a C-terminal ER luminal domain to sense stress (14) . Each UPR transducer is localized to the ER membrane, and is constitutively expressed in all known metazoan cells.
Upon accumulation of unfolded proteins in the ER, the UPR is activated to reduce the amount of new protein translocated into the ER lumen, to increase retrotranslocation and degradation of ER-localized proteins, and to bolster the protein-folding capacity and secretion potential of the ER. The UPR is orchestrated by transcriptional activation of An essential unresolved issue for UPR signaling is how the different transducers are activated by a common stimulus, the accumulation of unfolded proteins in the ER lumen. Current studies support that an ER chaperone protein, BiP (also known as GRP78), serves as a master UPR regulator and plays essential roles in activating IRE1, PERK, and ATF6 in response to ER stress (15) (16) (17) . BiP is a peptide-dependent ATPase and member of the heat shock 70 protein family that binds transiently to newly synthesized proteins translocated into the ER and more permanently to underglycosylated, misfolded or unassembled proteins. Under non-stressed conditions, BiP also binds to the luminal domains of IRE1, PERK, and ATF6 to maintain them within the ER. Upon accumulation of unfolded proteins, BiP is released from IRE1 and PERK to permit their spontaneous dimerization/oligomerization, transautophosphorylation, and subsequent activation (16, 18) . Release of ATF6 from BiP permits ATF6 transport to the Golgi compartment where it is cleaved to generate the cytosolic domain of ATF6 that translocates to the nucleus to activate transcription (17) .
Thus, this BiP-regulated activation provides a direct mechanism for all three UPR transducers to sense the "stress" in the ER and an autoregulatory mechanism by which the UPR is shut off upon increased expression of BiP ( Figure 1 ).
UPR Signaling Mediated by IRE1 and ATF6
To deal with accumulation of unfolded or misfolded protein caused by ER stress, UPR is activated to alter transcriptional programs through IRE1 and ATF6 ( Figure 2 ). In yeast, ER stress induces IRE1 homo-dimerization and trans-autophosphorylation to activate its RNase activity to initiate removal of a 252-base intron from the mRNA encoding the transcription factor HAC1 (19) . Splicing of HAC1 mRNA increases its translational efficiency and alters the carboxy-terminal sequence of HAC1 protein to generate a potent transcriptional activator. The protein encoded by spliced HAC1 mRNA binds and activates transcription from the UPR element (UPRE, minimal motif TGACGTGC/A) upstream of many UPR target genes (2, 20) . Analysis of the promoter regions of UPR-inducible genes in mammals, such as BiP, GRP94 and calreticulin, identified a mammalian ER stress response element (ERSE, minimal motif:
CCAAT(N 9 )CCACG) that is necessary and sufficient for UPR gene activation (21) . By using an ERSE as a probe in a yeast one-hybrid screen, two UPR-specific b-ZIP transcription factors, the X-box DNA binding protein (XBP1) and ATF6, were isolated.
XBP1 was identified as a homologue of yeast HAC1 that is a substrate for mammalian IRE1 RNase activity (22) (23) (24) . On activation of the UPR, IRE1 RNase cleaves XBP1 mRNA to remove a 26-nucleotide intron, generating a translational frame-shift. As the precedent of HAC1 regulation in yeast, the spliced XBP1 mRNA encodes a protein with a novel carboxy-terminus that acts as a potent transcription activator for many UPR target genes.
ATF6 is a UPR transducer that can bind ERSE elements in the promoters of UPR responsive genes (21) . There are two forms of ATF6, ATF6α (90 kDa) and ATF6β (110 kD, also known as CREB-RP), both of which require the presence of the transcription factor NF-Y to bind to an ERSE (14, 25, 26) . On activation of the UPR, ATF6 is transported to Golgi where it is cleaved by site-1 protease (S1P) and site-2 protease (S2P) to generate a 50 kD cytosolic b-ZIP-containing fragment that migrates to the nucleus to activate transcription of UPR target genes (17, 27) (Figure 2) . Notably, S1P and S2P are also the processing enzymes that cleave the ER-associated transmembrane sterolresponse element binding protein (SREBP) upon cholesterol deprivation. The cytosolic fragment of cleaved SREBP migrates to the nucleus to activate transcription of genes required for sterol biosynthesis (27) .
ATF6 regulates a group of genes encoding ER-resident molecular chaperones and genes encoding folding enzymes, while XBP1 regulates a subset of ER resident chaperone genes that are essential for protein folding, maturation, and degradation in the ER (28, 29) . It was previously proposed that XBP-1 mRNA is induced by ATF6 in response to ER stress to generate more substrate XBP-1 mRNA for IRE1-mediated splicing (22, 25, 30) . However, UPR induction of XBP1 transcripts and proteins was not altered in the cells having defective or reduced ATF6 cleavage (29, 30) . Induction of ATF6 mRNA upon ER stress was partially compromised in the absence of XBP-1, therefore it was proposed that ATF6 lies downstream of XBP-1 in some cases (29) . These results suggest that XBP1 and ATF6 are situated largely in parallel pathways and may interact with each other upon ER stress.
UPR Signaling Mediated by PERK
The most immediate response to ER stress is transient attenuation of mRNA translation by increased phosphorylation of eIF2α (31) . When eIF2α is phosphorylated, the formation of the ternary translation initiation complex eIF2/GTP/Met-tRNA i Met is prevented, leading to attenuation of translation in general. The ER-resident kinase PERK is activated in response to ER stress to phosphorylate eIF2α on Ser51, thereby attenuating protein synthesis to reduce the workload of the ER (32-34) (Figure 3 ). Murine cells deleted in PERK or mutated at Ser51 in eIF2α to prevent phosphorylation did not attenuate protein synthesis upon ER stress. As a consequence, these cells were not able to survive ER stress (32) . However, it was surprising that the increased ER stress-induced apoptosis in these cells was due to defective transcriptional activation of UPR genes 
ER Stress-Associated Protein Degradation and Programmed Cell Death
Protein folding in the oxidizing environment of the ER is an energy-requiring process (38, 39) . On the other hand, if the overload of unfolded or misfolded proteins in the ER is not resolved, prolonged activation of the UPR would lead to programmed cell death.
Three known pro-apoptotic pathways emanating from the ER are mediated by IRE1, caspase-12, and PERK/CHOP, respectively, although the mechanisms are unclear (1, 36) .
Under the ER stress, activated IRE1 can bind c-Jun-N-terminal inhibitory kinase (JIK) and recruit cytosolic adapter TRAF2, that signals through apoptosis-signaling kinase 1 (ASK1) and the JNK protein kinase to activate mitochondria/Apaf1-dependent apoptosis (46) (47) (48) . Caspase-12 is an ER-associated proximal effector of the caspase activation cascade, and cells defective in this enzyme are partially resistant to ER stress-induced apoptosis (49) . Under ER stress, activated caspase-12 activates caspase-9, which in turn activates caspase-3, leading to apoptosis (49, 50) . CHOP is a b-ZIP transcription factor that induces expression of genes favoring apoptosis in response to ER stress (36).
Prolonged UPR activation leads to expression of transcription factor ATF4 through the PERK-eIF2α pathway. ATF4 then induces expression of CHOP, which subsequently activates caspase-3 through unknown intermediates (34, 51) . UPR signaling is also essential to maintain glucose homeostasis. In this respect, it is interesting to note that the UPR was first characterized as transcriptional activation of a set of genes, encoding glucose-regulated proteins (GRPs), in response to glucose/energy deprivation (58) . We now know that pancreatic β-cells uniquely require the UPR for survival during intermittent fluctuations in blood glucose (32, 59) . Humans and mice with deletions in PERK have a profound pancreatic β-cell dysfunction and develop infancyonset diabetes (59, 60) . In addition, mice with a mutation at the eIF2α phosphorylation site display a severe β-cell dysfunction (59) . A model that blood glucose levels influence the protein-folding status in the ER of the β−cell has been proposed: as glucose levels decline, the energy supply decreases, so protein folding becomes inefficient in the ER and therefore activates the PERK-eIF2α sub-pathway of the UPR to attenuate protein translation. Conversely, as blood glucose levels rise, eIF2α would be dephosphorylated so that translation would accelerate to increase proinsulin synthesis (32) . In addition, continual elevation in blood glucose, such as that which occurs during insulin resistance, would prolong proinsulin translation to overload the ER folding capacity and thereby activate the UPR. In this manner, a balance between glucose level and PERK-eIF2α UPR signaling is essential for regulated translation of insulin, β-cell function and survival.
The Physiological Roles of the UPR

Concluding Remarks
Significant progress has been made in identifying components of the UPR pathways and in understanding physiological roles of the UPR. However, our knowledge of the UPR pathway is still incomplete. There remains much to do in identifying new substrates for the known UPR transducers and new transducers for unknown UPR pathways. Furthermore, it will be extremely important to elucidate the sensing mechanisms for the UPR transducers under different physiological conditions. Studies of this most upstream event in the UPR promise to expand our understanding of the UPR signaling pathway itself and its physiological functions. It is known that a variety of environmental insults and genetic diseases result in accumulation of unfolded or misfolded proteins in the ER that contribute to the pathogenesis of different disease states. As new animal models with defects in different signaling components of the UPR are generated, a more precise knowledge of the extent to which these pathways cause or arise as a consequence of different pathological conditions will be gained. Elucidating 
